These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 11911810

  • 41. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
    Fulda S, Meyer E, Debatin KM.
    Oncogene; 2002 Apr 04; 21(15):2283-94. PubMed ID: 11948412
    [Abstract] [Full Text] [Related]

  • 42. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 43. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
    Weng C, Li Y, Xu D, Shi Y, Tang H.
    J Biol Chem; 2005 Mar 18; 280(11):10491-500. PubMed ID: 15637055
    [Abstract] [Full Text] [Related]

  • 44. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells.
    Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T.
    Oncogene; 2004 Aug 19; 23(37):6261-71. PubMed ID: 15208660
    [Abstract] [Full Text] [Related]

  • 45. Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway.
    Wagner KW, Engels IH, Deveraux QL.
    J Biol Chem; 2004 Aug 13; 279(33):35047-52. PubMed ID: 15173176
    [Abstract] [Full Text] [Related]

  • 46. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.
    Zhu H, Guo W, Zhang L, Wu S, Teraishi F, Davis JJ, Dong F, Fang B.
    Cancer Biol Ther; 2005 Jul 13; 4(7):781-6. PubMed ID: 16082182
    [Abstract] [Full Text] [Related]

  • 47. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.
    Abdollahi T, Robertson NM, Abdollahi A, Litwack G.
    Cancer Res; 2003 Aug 01; 63(15):4521-6. PubMed ID: 12907626
    [Abstract] [Full Text] [Related]

  • 48. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.
    J Biol Chem; 2003 Nov 07; 278(45):44338-47. PubMed ID: 12920112
    [Abstract] [Full Text] [Related]

  • 49. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.
    Deng Y, Lin Y, Wu X.
    Genes Dev; 2002 Jan 01; 16(1):33-45. PubMed ID: 11782443
    [Abstract] [Full Text] [Related]

  • 50. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2004 Oct 01; 25(10):1867-77. PubMed ID: 15205359
    [Abstract] [Full Text] [Related]

  • 51. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.
    Ramp U, Caliskan E, Mahotka C, Krieg A, Heikaus S, Gabbert HE, Gerharz CD.
    Br J Cancer; 2003 Jun 02; 88(11):1800-7. PubMed ID: 12771998
    [Abstract] [Full Text] [Related]

  • 52. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
    Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ.
    Oncogene; 2001 Sep 13; 20(41):5789-98. PubMed ID: 11593384
    [Abstract] [Full Text] [Related]

  • 53. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.
    Johnson TR, Stone K, Nikrad M, Yeh T, Zong WX, Thompson CB, Nesterov A, Kraft AS.
    Oncogene; 2003 Aug 07; 22(32):4953-63. PubMed ID: 12902978
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ.
    Cancer Res; 2004 May 15; 64(10):3517-24. PubMed ID: 15150106
    [Abstract] [Full Text] [Related]

  • 57. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS, Poukkula M, Holmström TH, Heiskanen KM, Eriksson JE.
    J Immunol; 2002 Sep 15; 169(6):2851-60. PubMed ID: 12218097
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 15; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 60. Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.
    Miao L, Yi P, Wang Y, Wu M.
    Eur J Biochem; 2003 Jul 15; 270(13):2721-31. PubMed ID: 12823542
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.